BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Motilal Oswal maintains buy on Aurobindo Pharma
Motilal Oswal has maintained buy on Aurobindo Pharma for target price of Rs 1,100 per share. MOSL says US business to double in three years and improving mix to boost margins. It expects 27% EPS CAGR over FY'15-18.